A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage mutated p53. This essential cancer inhibitor protein is frequently lost in various kinds of malignancies, leading https://directmysocial.com/story6745019/vhh-fragments-reactivate-the-p53-protein-a-potential-hope-for-cancer-therapy